vs
IRIDEX CORP（IRIX）与Rocky Mountain Chocolate Factory, Inc.（RMCF）财务数据对比。点击上方公司名可切换其他公司
IRIDEX CORP的季度营收约是Rocky Mountain Chocolate Factory, Inc.的2.0倍（$14.7M vs $7.5M），Rocky Mountain Chocolate Factory, Inc.同比增速更快（-4.4% vs -69.7%），过去两年IRIDEX CORP的营收复合增速更高（11.9% vs 1.9%）
IRIDEX Corporation是一家全球性医疗科技企业，主要研发、生产和销售面向眼科及医疗美容领域的激光类医疗设备，产品供应至北美、欧洲、亚太等地区的医疗机构与诊所，为眼部疾病治疗和医美项目提供微创解决方案。
落基山巧克力厂是美国知名巧克力企业，同时开展国际特许经营业务，集糖果生产与零售运营于一体，总部位于美国科罗拉多州杜兰戈，除美国本土门店外，在巴拿马、菲律宾也设有经营网点。
IRIX vs RMCF — 直观对比
营收规模更大
IRIX
是对方的2.0倍
$7.5M
营收增速更快
RMCF
高出65.3%
-69.7%
两年增速更快
IRIX
近两年复合增速
1.9%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $14.7M | $7.5M |
| 净利润 | — | $-155.0K |
| 毛利率 | 37.2% | 34.0% |
| 营业利润率 | — | 1.1% |
| 净利率 | — | -2.1% |
| 营收同比 | -69.7% | -4.4% |
| 净利润同比 | — | 81.7% |
| 每股收益（稀释后） | — | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IRIXRMCF
| Q4 25 | $14.7M | $7.5M | ||
| Q3 25 | $12.5M | $6.8M | ||
| Q2 25 | $13.6M | $6.4M | ||
| Q1 25 | $11.9M | $8.9M | ||
| Q4 24 | $12.7M | $7.9M | ||
| Q3 24 | $11.6M | $6.4M | ||
| Q2 24 | $12.6M | $6.4M | ||
| Q1 24 | $11.8M | $7.3M |
净利润IRIXRMCF
| Q4 25 | — | $-155.0K | ||
| Q3 25 | $-1.6M | $-662.0K | ||
| Q2 25 | $-994.0K | $-324.0K | ||
| Q1 25 | $-1.7M | $-2.9M | ||
| Q4 24 | $-834.0K | $-847.0K | ||
| Q3 24 | $-1.9M | $-722.0K | ||
| Q2 24 | $-2.7M | $-1.7M | ||
| Q1 24 | $-3.5M | $-1.6M |
毛利率IRIXRMCF
| Q4 25 | 37.2% | 34.0% | ||
| Q3 25 | 32.1% | 23.6% | ||
| Q2 25 | 34.5% | 31.1% | ||
| Q1 25 | 42.5% | 10.8% | ||
| Q4 24 | 44.0% | 23.4% | ||
| Q3 24 | 37.3% | 31.8% | ||
| Q2 24 | 40.7% | 12.8% | ||
| Q1 24 | 37.9% | 24.3% |
营业利润率IRIXRMCF
| Q4 25 | — | 1.1% | ||
| Q3 25 | -11.3% | -7.0% | ||
| Q2 25 | -6.9% | -2.3% | ||
| Q1 25 | -1.7% | -30.3% | ||
| Q4 24 | -3.9% | -8.9% | ||
| Q3 24 | -16.1% | -14.3% | ||
| Q2 24 | -20.9% | -25.4% | ||
| Q1 24 | -28.0% | -21.7% |
净利率IRIXRMCF
| Q4 25 | — | -2.1% | ||
| Q3 25 | -12.6% | -9.7% | ||
| Q2 25 | -7.3% | -5.1% | ||
| Q1 25 | -14.2% | -32.5% | ||
| Q4 24 | -6.6% | -10.7% | ||
| Q3 24 | -16.7% | -11.3% | ||
| Q2 24 | -21.2% | -25.9% | ||
| Q1 24 | -29.5% | -21.9% |
每股收益（稀释后）IRIXRMCF
| Q4 25 | — | $-0.02 | ||
| Q3 25 | $-0.09 | $-0.09 | ||
| Q2 25 | $-0.06 | $-0.04 | ||
| Q1 25 | $-0.10 | $-0.38 | ||
| Q4 24 | $-0.05 | $-0.11 | ||
| Q3 24 | $-0.12 | $-0.11 | ||
| Q2 24 | $-0.16 | $-0.26 | ||
| Q1 24 | $-0.21 | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.0M | $641.0K |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $6.0M |
| 总资产 | $29.2M | $20.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IRIXRMCF
| Q4 25 | $6.0M | $641.0K | ||
| Q3 25 | $5.6M | $2.0M | ||
| Q2 25 | $6.8M | $893.0K | ||
| Q1 25 | $7.2M | $720.0K | ||
| Q4 24 | $2.4M | $1.1M | ||
| Q3 24 | $3.9M | $973.0K | ||
| Q2 24 | $4.1M | $637.0K | ||
| Q1 24 | $5.4M | $2.1M |
总债务IRIXRMCF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.0M | — | ||
| Q3 24 | $1.4M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益IRIXRMCF
| Q4 25 | — | $6.0M | ||
| Q3 25 | $4.7M | $6.1M | ||
| Q2 25 | $6.1M | $6.7M | ||
| Q1 25 | $852.0K | $7.0M | ||
| Q4 24 | $2.1M | $9.8M | ||
| Q3 24 | $2.6M | $10.5M | ||
| Q2 24 | $4.2M | $9.0M | ||
| Q1 24 | $6.5M | $10.6M |
总资产IRIXRMCF
| Q4 25 | $29.2M | $20.7M | ||
| Q3 25 | $28.4M | $22.3M | ||
| Q2 25 | $31.6M | $20.1M | ||
| Q1 25 | $34.2M | $21.2M | ||
| Q4 24 | $29.1M | $21.6M | ||
| Q3 24 | $30.2M | $21.1M | ||
| Q2 24 | $31.2M | $19.0M | ||
| Q1 24 | $34.1M | $20.6M |
负债/权益比IRIXRMCF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.48× | — | ||
| Q3 24 | 0.53× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-1.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-1.3M |
| 自由现金流率自由现金流/营收 | — | -16.9% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流IRIXRMCF
| Q4 25 | — | $-1.2M | ||
| Q3 25 | $-1.2M | $-488.0K | ||
| Q2 25 | $-397.0K | $350.0K | ||
| Q1 25 | $-1.1M | $1.2M | ||
| Q4 24 | $-1.2M | $-2.1M | ||
| Q3 24 | $-3.1M | $-3.5M | ||
| Q2 24 | $-1.3M | $-2.2M | ||
| Q1 24 | $-1.6M | $129.0K |
自由现金流IRIXRMCF
| Q4 25 | — | $-1.3M | ||
| Q3 25 | $-1.2M | $-544.0K | ||
| Q2 25 | $-410.0K | $182.0K | ||
| Q1 25 | $-1.2M | — | ||
| Q4 24 | $-1.2M | — | ||
| Q3 24 | $-3.1M | $-4.6M | ||
| Q2 24 | — | $-2.6M | ||
| Q1 24 | $-1.7M | $-352.3K |
自由现金流率IRIXRMCF
| Q4 25 | — | -16.9% | ||
| Q3 25 | -9.4% | -8.0% | ||
| Q2 25 | -3.0% | 2.9% | ||
| Q1 25 | -9.8% | — | ||
| Q4 24 | -9.8% | — | ||
| Q3 24 | -26.5% | -72.6% | ||
| Q2 24 | — | -40.2% | ||
| Q1 24 | -14.0% | -4.9% |
资本支出强度IRIXRMCF
| Q4 25 | — | 0.5% | ||
| Q3 25 | 0.1% | 0.8% | ||
| Q2 25 | 0.1% | 2.6% | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.0% | 17.5% | ||
| Q2 24 | 0.0% | 6.5% | ||
| Q1 24 | 0.0% | 6.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IRIX
暂无分部数据
RMCF
| Manufacturing | $5.9M | 78% |
| Transferred At Point In Time | $1.2M | 16% |
| Other | $414.0K | 5% |
